AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
samaneh mirzaei
Clinical Research Development Center, Shahid Rahnemoon Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
IRAN
Public Documents
1
Impact of IFN- β1a in treatment of a COVID-19 Patient with Beta Thalassemia and Diabe...
mohsen gholinataj jelodar
and 2 more
February 10, 2022
The present study aimed to report a case with COVID-19 with a history of chronic diseases, beta thalassemia intermedia, and DM. A 25-year-old man visited with covid 19 and treatment with IFN-β1a. According to the present report, the use of IFN-β1a was effective as a treatment option for COVID-19.
